Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility

CLEVELAND, Sept. 02, 2021 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTC Mkts: VBIO) (Vitality or the Company), an innovation-driven drug development company dedicated to unlocking the therapeutic powers of cannabinoids, today announced that the Securities…

Click here to view the original article.